The Pivotal Role of GR‐CAR Pathway in Fetal Programming of Hepatic Cytochrome P450 3A Alteration in Adulthood

Prenatal dexamethasone exposure (PDE) persistently upregulates hepatic CYP3A1/CYP2B1 in offspring via glucocorticoid receptor (GR) activation. In vivo and in vitro studies show GR promotes P300/CBP binding to the constitutive androstane receptor (CAR) promoter, sustaining histone acetylation (H3K9/K27ac) and enhancing CYP expression. The GR–CAR pathway programs metabolic changes, explaining individual variation in drug metabolism. Abstract Multiple prenatal adverse environmental factors alter hepatic cytochrome P450 (CYP) enzymes expression in offspring, with these changes persisting after birth. These factors induce fetal exposure to excessive maternal glucocorticoids (GCs), however, the mechanisms by which intrauterine GCs exposure programs offspring CYP expression remain unclear. Given that GCs are high‐affinity ligands for the glucocorticoid receptor (GR), this work employs dexamethasone (DEX), a GR agonist, to establish a prenatal dexamethasone exposure (PDE) model for investigating the role of GR activation in CYPs programming. The model is implemented to pregnant Wistar rats and heterozygous liver‐specific GR knockout mice. Results show that PDE consistently increases the expression of hepatic CYP3A1 and CYP2B1, thereby enhancing the metabolic enzyme efficiency in adult male offspring. In vitro experiment further validates that GC‐induced activation of GR increases the binding of P300/cAMP response element‐binding protein (CBP) to the promoter region of constitutive androstane receptor (CAR), which leads to sustained H3K9 and H3K27 acetylation at the CAR locus, indirectly promoting CYP expression in adult offspring. Conclusively, the GR‐CAR pathway may play a pivotal role in programming CYP3A alteration in offspring exposed to elevated intrauterine GCs. This study provides novel insights into individual variations of CYPs expression and metabolic patterns. Prenatal dexamethasone exposure (PDE) persistently upregulates hepatic CYP3A1/CYP2B1 in offspring via glucocorticoid receptor (GR) activation. In vivo and in vitro studies show GR promotes P300/CBP binding to the constitutive androstane receptor (CAR) promoter, sustaining histone acetylation (H3K9/K27ac) and enhancing CYP expression. The GR–CAR pathway programs metabolic changes, explaining individual variation in drug metabolism. Abstract Multiple prenatal adverse environmental factors alter hepatic cytochrome P450 (CYP) enzymes expression in offspring, with these changes persisting after birth. These factors induce fetal exposure to excessive maternal glucocorticoids (GCs), however, the mechanisms by which intrauterine GCs exposure programs offspring CYP expression remain unclear. Given that GCs are high-affinity ligands for the glucocorticoid receptor (GR), this work employs dexamethasone (DEX), a GR agonist, to establish a prenatal dexamethasone exposure (PDE) model for investigating the role of GR activation in CYPs programming. The model is implemented to pregnant Wistar rats and heterozygous liver-specific GR knockout mice. Results show that PDE consistently increases the expression of hepatic CYP3A1 and CYP2B1, thereby enhancing the metabolic enzyme efficiency in adult male offspring. In vitro experiment further validates that GC-induced activation of GR increases the binding of P300/cAMP response element-binding protein (CBP) to the promoter region of constitutive androstane receptor (CAR), which leads to sustained H3K9 and H3K27 acetylation at the CAR locus, indirectly promoting CYP expression in adult offspring. Conclusively, the GR-CAR pathway may play a pivotal role in programming CYP3A alteration in offspring exposed to elevated intrauterine GCs. This study provides novel insights into individual variations of CYPs expression and metabolic patterns. Advanced Science, EarlyView.